File Size : 758 Kbyte
Approximate download time:
hoursminutesseconds
Modeling the Cost Effectiveness of Etanercept, Adalimumab and Anakinra Compared to Infliximab in the Treatment of Patients with Rheumatoid Arthritis in the Medicare Program.
Agency for Healthcare Research and Quality, Rockville, MD.
ProductType: Technical report
Product Source: AHRQ
NTIS Order Number: PB2007-102051



 
Media Count: N/A
Date: Oct 2006
Author: N/A

A cost effectiveness analysis of infliximab versus etanercept, adalimumab and anakinra has been performed from the viewpoint of Medicare as part of the Medicare Replacement Drug Demonstration Program. The model draws on synthesis of randomized controlled ...

Report Number: N/A
Contract Number: N/A
Project Number: N/A
Grant Number: N/A
Task Number: N/A
NTIS announcement issue: 0704

"N/A" indicates no data is available for this field.